- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Tyrosine Protein Kinase Inhibitors
Total 11476 results
-
National Cancer Institute (NCI)RecruitingGynecologic Cancer | Colorectal Neoplasms | Colorectal Cancer | Ovarian Neoplasms | Peritoneal Neoplasms | Ovarian Cancer | Peritoneal Carcinomatosis | Appendiceal Neoplasms | Appendiceal Cancer | Gynecologic NeoplasmsUnited States
-
CStone PharmaceuticalsRecruitingGastrointestinal Stromal TumorsChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | CD20 Positive | Refractory Mantle Cell Lymphoma | Blastoid Variant Mantle Cell Lymphoma | CCND1 Protein Overexpression | CD5 Positive | FCER2 Negative | Pleomorphic Variant Mantle Cell Lymphoma | t(11;14)(q13;q32)United States
-
H. Lee Moffitt Cancer Center and Research InstituteArray BioPharmaCompletedNon-Small Cell Lung Cancer | Lung CancerUnited States
-
AstraZenecaYgheaRecruitingChronic Lymphocytic LeukemiaItaly
-
Giselle ShollerY-mAbsRecruitingHigh-risk NeuroblastomaUnited States, Canada
-
Ikena OncologyRecruitingSolid Tumor | Solid Tumors, Adult | Malignant Pleural Mesothelioma (MPM) | Epithelioid Hemangioendothelioma (EHE) | NF2 Deficient Mesothelioma | Other NF2 Deficient Solid Tumors and Solid Tumors With YAP1/TAZ Fusion Genes | NF2 Deficiency | YAP1 or TAZ Gene FusionsUnited States, United Kingdom
-
Hoffmann-La RocheRecruitingCarcinoma, Non-Small-Cell LungBrazil, China, France, Croatia, Greece, Italy, Mexico, Spain, India, Netherlands, Romania, Sweden, Thailand, Lebanon, Turkey, Slovakia, Jordan, Russian Federation, Germany
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Small Lymphocytic Lymphoma | Richter's SyndromeUnited States, United Kingdom, Italy
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungSpain, Israel, Italy, Austria, Czechia, Greece, Australia, Poland, Hungary, Portugal, Russian Federation
-
Jorge J. Castillo, MDBristol-Myers SquibbTerminated
-
Gruppo Italiano Malattie EMatologiche dell'AdultoFundacion Espanola para la Curacion de la Leucemia Mieloide CronicaNot yet recruitingChronic Myeloid Leukemia | Chronic Myeloid Leukemia, Chronic Phase | CML, Chronic Phase | Chronic Myeloid Leukemia, BCR/ABL-Positive
-
Joshua PalmerGenentech, Inc.RecruitingNSCLC | Lung Cancer | Brain MetastasesUnited States
-
Prelude TherapeuticsBeiGeneRecruitingT-cell Lymphoma | Mantle Cell Lymphoma (MCL) | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Richter's Syndrome | Aggressive B-Cell Non-Hodgkin's Lymphoma | Aggressive B-Cell NHLUnited States, Canada, Korea, Republic of, Australia, France, Poland, Italy, Germany, Switzerland, United Kingdom
-
M.D. Anderson Cancer CenterAriad PharmaceuticalsTerminatedLeukemiaUnited States
-
Janssen Research & Development, LLCCompletedWaldenstrom MacroglobulinemiaChina
-
Ascentage Pharma Group Inc.HealthQuest Pharma Inc.Recruiting
-
AstraZenecaRecruitingNon-Small Cell Lung CancerUnited States, Spain, China, Italy, Turkey, Argentina, United Kingdom, Canada, Germany, Brazil, Vietnam, Thailand, Poland, Russian Federation, Japan, Korea, Republic of, Taiwan, Malaysia, Singapore, Romania
-
H. Lee Moffitt Cancer Center and Research InstituteBoehringer IngelheimRecruitingSquamous Cell CarcinomaUnited States
-
BeiGeneRecruitingWaldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUnited States
-
Novartis PharmaceuticalsRecruitingAcute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma | Small Lymphocytic Lymphoma | Large B-cell LymphomaJapan, Australia, Germany, Italy, Spain, France, Austria, United States
-
Hoffmann-La RocheRecruitingNeoplasmsItaly, France, Turkey, Korea, Republic of, Spain, China, United States, Hong Kong, Russian Federation, Poland
-
Acerta Pharma BVActive, not recruitingGlioblastoma MultiformeUnited States
-
Io TherapeuticsDartmouth CollegeSuspendedLung Cancer, Nonsmall CellUnited States
-
Korea University Guro HospitalKorean Cancer Study GroupActive, not recruitingMetastatic Cancer | HER2 Gene MutationKorea, Republic of
-
Sun Yat-sen UniversityNot yet recruitingEndometrial Cancer | Endometrial AdenocarcinomaChina
-
Tata Memorial HospitalRecruitingCarcinoma, HepatocellularIndia
-
Tianjin Medical University Cancer Institute and...RecruitingNon-small Cell Lung Cancer | EGFR Activating Mutation | EGFR-TKI Resistant Mutation | Cell Cycle DeregulationChina
-
Loxo Oncology, Inc.Eli Lilly and CompanyRecruitingChronic Lymphocytic Leukemia | Leukemia, B-cell | Small Lymphocytic Lymphoma | Leukemia, LymphocyticUnited States, Spain, Canada, Korea, Republic of, Taiwan, Australia, Japan, New Zealand, Italy, Czechia, China, Hungary, Israel, Belgium, France, Poland, Germany, Argentina, United Kingdom, Brazil, Turkey, Chile, Austria
-
AstraZenecaHutchison MediPharmaRecruitingCarcinomaDenmark, Spain, United States, Taiwan, Vietnam, Canada, Korea, Republic of, Brazil, India, Japan, Italy, Puerto Rico, France, Chile
-
Dana-Farber Cancer InstituteBristol-Myers SquibbTerminatedWaldenstrom's MacroglobulinemiaUnited States
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaUnited States, United Kingdom, Belgium, Spain, Israel, France
-
Hoffmann-La RocheActive, not recruitingAnaplastic Lymphoma Kinase-positive Non-small Cell Lung CancerChina, Korea, Republic of, Thailand
-
German CLL Study GroupActive, not recruitingChronic Lymphoid LeukemiaAustria, Germany
-
Versailles HospitalActive, not recruiting
-
Fudan UniversityNot yet recruitingLung Cancer | Minimal Residual Disease | EGFR Gene Mutation
-
Washington University School of MedicineApollomics Inc.RecruitingMetastatic Non Small Cell Lung CancerUnited States
-
University of Texas Southwestern Medical CenterAstraZenecaActive, not recruitingNon-small Cell Lung Cancer (NSCLC)United States
-
German Cancer Research CenterGerman Consortium for Translational Cancer ResearchCompletedMetastatic and Locally Advanced NRG1-rearranged MalignanciesGermany
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Refractory Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States, Canada, Singapore
-
Fudan UniversityRecruitingMantle Cell Lymphoma | Maintenance TherapyChina
-
Janssen Cilag S.A.S.RecruitingLeukemia, Lymphocytic, Chronic, B-CellFrance
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous LeukemiaUnited States, United Kingdom, Hungary, Japan, Saudi Arabia, Australia, Germany, Canada, France, Netherlands, Spain, Lebanon, Turkey, Korea, Republic of, Argentina, Brazil, Bulgaria, Czechia, Israel, Italy, Mexico, Romania, Russian... and more
-
BeiGeneActive, not recruiting
-
Shanghai Zhongshan HospitalUnknownMyeloproliferative Neoplasm | Gastroesophageal Varices | JAK2 Mutation
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedRecurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Adenocarcinoma of the Lung | Large Cell Lung CancerUnited States
-
National Cancer Institute (NCI)RecruitingInherited Bone Marrow Failure Syndrome | Familial Platelet Disorder With Predisposition to Myeloid MalignanciesUnited States
-
Novartis PharmaceuticalsRecruitingPhiladelphia Chromosome-Positive Chronic Myeloid LeukemiaSingapore, France, Germany, United Arab Emirates, Greece, Italy, Czechia, Hungary, United States, India, Oman, Malaysia, Korea, Republic of, Turkey, Bulgaria, Canada, Slovakia, United Kingdom, Argentina, Jordan, Romania, South Africa and more